AbCellera
control immunity to generate better diversity we generate and access a high quality universe of antibodies for any target proprietary immunization methods any source any tissue human antibodies from rodents we trigger immune responses from any species with the goal of generating the best antibodies with the most diversity | AbCellera
Company
Deck Type
Sector
Industry
Deck date
July 2022
Slide
22 of 37
Related slides by other companies
OmniAb
Investor Conference
November 2022
greater evolutionary distance yields greater immunogenicity and more antibody diversity | OmniAb
Other recent decks by AbCellera
See all presentations (23 decks)
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights